110 related articles for article (PubMed ID: 23224740)
21. Identification and Validation of a New Peptide Targeting Pancreatic Beta Cells.
Wang Q; Zheng L; Wu K; Zhang B
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408679
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [
Migliari S; Sammartano A; Boss M; Gotthardt M; Scarlattei M; Baldari G; Silva C; Bonadonna RC; Ruffini L
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056858
[No Abstract] [Full Text] [Related]
23. Exendin-4-Conjugated Manganese Magnetism-Engineered Iron Oxide Nanoparticles as a Potential Magnetic Resonance Imaging Contrast Agent for Tracking Transplanted β-Cells.
Juang JH; Shen CR; Wang JJ; Wu ST; Lin SH; Chen CY; Kao CW; Chen CL; Tsai ZT; Wang YM
Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835906
[TBL] [Abstract][Full Text] [Related]
24. Current update on imaging for pancreatic neuroendocrine neoplasms.
Segaran N; Devine C; Wang M; Ganeshan D
World J Clin Oncol; 2021 Oct; 12(10):897-911. PubMed ID: 34733612
[TBL] [Abstract][Full Text] [Related]
25. The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.
Kahn SE; Chen YC; Esser N; Taylor AJ; van Raalte DH; Zraika S; Verchere CB
Endocr Rev; 2021 Sep; 42(5):528-583. PubMed ID: 34180979
[TBL] [Abstract][Full Text] [Related]
26. NHS-Functionalized THP Derivative for Efficient Synthesis of Kit-Based Precursors for
Floresta G; Keeling GP; Memdouh S; Meszaros LK; de Rosales RTM; Abbate V
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33915871
[TBL] [Abstract][Full Text] [Related]
27. Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge.
Dardano A; Daniele G; Lupi R; Napoli N; Campani D; Boggi U; Del Prato S; Miccoli R
Front Endocrinol (Lausanne); 2020; 11():10. PubMed ID: 32047477
[No Abstract] [Full Text] [Related]
28. Innovative imaging of insulinoma: the end of sampling? A review.
Christ E; Antwi K; Fani M; Wild D
Endocr Relat Cancer; 2020 Apr; 27(4):R79-R92. PubMed ID: 31951592
[TBL] [Abstract][Full Text] [Related]
29. Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics.
Velikyan I; Eriksson O
Theranostics; 2020; 10(1):437-461. PubMed ID: 31903131
[TBL] [Abstract][Full Text] [Related]
30.
Briganti V; Cuccurullo V; Berti V; Di Stasio GD; Linguanti F; Mungai F; Mansi L
Curr Radiopharm; 2020; 13(3):166-176. PubMed ID: 31886756
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of ASVS for insulinoma localization: A systematic review and meta-analysis.
Wang H; Ba Y; Xing Q; Cai RC
PLoS One; 2019; 14(11):e0224928. PubMed ID: 31743337
[TBL] [Abstract][Full Text] [Related]
32. Preliminary evaluation of 18F‑AlF‑NOTA‑MAL‑Cys40‑Exendin‑4 in rodent heart after myocardial ischemia and reperfusion.
Pan X; Xu Q; Chen J; Wang T; Zhang M; Wang H; Gao H
Mol Med Rep; 2019 Sep; 20(3):2276-2284. PubMed ID: 31257516
[TBL] [Abstract][Full Text] [Related]
33. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
[TBL] [Abstract][Full Text] [Related]
34. Exendin-4 analogs in insulinoma theranostics.
Jansen TJP; van Lith SAM; Boss M; Brom M; Joosten L; Béhé M; Buitinga M; Gotthardt M
J Labelled Comp Radiopharm; 2019 Aug; 62(10):656-672. PubMed ID: 31070270
[TBL] [Abstract][Full Text] [Related]
35. Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas.
Pallavi UN; Malasani V; Sen I; Thakral P; Dureja S; Pant V; Gaikwad VS; Sabharwal A
Indian J Nucl Med; 2019; 34(1):14-18. PubMed ID: 30713372
[TBL] [Abstract][Full Text] [Related]
36. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
Antwi K; Fani M; Heye T; Nicolas G; Rottenburger C; Kaul F; Merkle E; Zech CJ; Boll D; Vogt DR; Gloor B; Christ E; Wild D
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2318-2327. PubMed ID: 30054698
[TBL] [Abstract][Full Text] [Related]
37. Fully automated GMP production of [
Velikyan I; Rosenstrom U; Eriksson O
Am J Nucl Med Mol Imaging; 2017; 7(3):111-125. PubMed ID: 28721305
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.
Joosten L; Brom M; Schäfer MKH; Boerman OC; Weihe E; Gotthardt M
Sci Rep; 2017 May; 7(1):1751. PubMed ID: 28496188
[TBL] [Abstract][Full Text] [Related]
39. Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.
Fani M; Peitl PK; Velikyan I
Pharmaceuticals (Basel); 2017 Mar; 10(1):. PubMed ID: 28295000
[No Abstract] [Full Text] [Related]
40. Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.
Läppchen T; Tönnesmann R; Eersels J; Meyer PT; Maecke HR; Rylova SN
PLoS One; 2017; 12(1):e0170435. PubMed ID: 28103285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
